NCT01523496

Vitamin D Supplementation in HIV Youth

Vitamin D Supplementation and HIV-related Complications in Children and Young Adults

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 190 (actual)
• Sponsor: University Hospitals Cleveland Medical Center · Academic / Other
• Sex: All
• Age: 8 Years – 25 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine the correct dose of Vitamin D to give to prevent HIV related complications.

Detailed description

The purpose of the this study was to compare control dose of vitamin D (low dose of 600 IU/d) to supplementation dose (medium dose of 2000 IU/d or higher doses of vitamin D of 4000 IU/d) on HIV-related comorbidities including immune activation, inflammation, cardiovascular diseases, and metabolic complications in HIV-infected youth.

Conditions

• HIV Infections

Interventions

Type	Name	Description
DRUG	Vitamin D control dose	18,000 IU per month
DRUG	Vitamin D supplementation-	60,000 IU per month(medium dose) or 120,000 IU/month(high dose)

Timeline

• Start date: 2011-12-01
• Primary completion: 2016-08-01
• Completion: 2016-08-01
• First posted: 2012-02-01
• Last updated: 2018-03-08
• Results posted: 2018-02-06

Locations

2 sites across 1 country: United States